EDITORIAL SECTION
-
STRATEGY
Strategic Positioning for M&A
The biotechnology sector is characterised by a constant influx of small highly specialised companies
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solutions help reduce contamination risk and lower manual handling
-
CLINICAL TRIALS
Virtual Clinical Trials
Virtual digital and decentralized are all descriptions of the novel ways that using technology changes
-
Bio Pharma
Biosimilars and Biobetters
Biosimilars are biologic medical products that are essentially identical to an original product manufactured
-
MANUFACTURING
Transformative Convergence of AI in Pharmaceutical Manufacturing
The pharmaceutical manufacturing industry is on the cusp of a revolutionary transformation driven by
-
Information Technology
Transformative Impact of Artificial Intelligence on Clinical Trials
Artificial Intelligence AI has rapidly evolved from a futuristic concept to a transformative tool across various industries
-
EXPERT Talk
Pharma's Medical Affairs Bridge: From Field Insights and Stakeholder Needs to Global Scientific Strategy
Medical Affairs has evolved from being primarily a supportive and educational function to becoming a strong strategic partner earlier on Through ongoi...
Advisory Board
.webp "Juris Hmelnickis")
.webp "Eiman Shafa")
KNOWLEDGE BANK
-
Articles
U.S. Pharmaceutical Intellectual Property Strategy: Patents, Exclusivity and Competitive Protection
Bringing a new drug to market can cost over a billion dollars and take a decade or more Copying that drug can cost a tiny fraction of that Without legal protection no company could recover its investment and fewer new medicines would reach patients
-
Techno Trends
Lilly’s Jaypirca Gains FDA Approval for First-Line CLL/SLL Treatment
Eli Lilly and Company has received approval from the US Food and Drug Administration FDA for an additional indication for Jaypirca pirtobrutinib in adults with previously untreated chronic lymphocytic leukaemia CLL or small lymphocytic lymphoma SLL without a known p deletion The approval enables Jaypirca to be used as a firstline treatment
-
Projects
Genentech Begins US$750 Million Expansion of Oregon Manufacturing Facility
Genentech a member of the Roche Group has started construction on a US million expansion of its manufacturing facility in Hillsboro Oregon The squarefoot project will double the existing sites footprint and increase US production capacity for advanced drug delivery devices
-
Research Insights
Identification of flavonoids from natural products against hyperlipidaemia through computational approaches
Over the centuries hyperlipidaemia has been recognised as a major risk factor contributing to cardiovascular disease CVD Current research increasingly explores natural compounds such as flavonoids for their potential lipidlowering effects This study evaluated pharmacological potential
-
White Papers
Post-Translational Modifications in Drug Discovery: From Molecular Regulation to Clinical Impact
For decades the central dogma of molecular biology has anchored our understanding of cellular function DNA to RNA to protein But this linear view is incomplete A growing body of evidence shows that much of biologys complexity
TOP ARTICLES
-
1
Prescribing Change: The Evolution of Digital Therapeutics in Medicine
Kate Williamson
Dive into the transformative realm of digital therapeutics reshaping modern healthcare. Explore personalized interventions, telemedicine's rise, precision medicine's data analytics, chronic di...
-
2
Navigating the Landscape of Pharmacogenomics in Diagnosis to Drug Delivery in Cancer Therapeutics
Vikas Jhawat
Monika Gulia
In the realm of cancer therapeutics, pharmacogenomics has emerged as a critical linchpin in shaping treatment decisions. The relentless adaptability of cancer cells, often culminating in resistance to...
-
3
Digital Biomarkers and Wearables: Transforming Clinical Trial Data Collection
Lakshmi
For decades, clinical trials have judged new medicines on brief snapshots captured during scheduled site visits. Digital biomarkers collected through wearables, sensors and smartphones are changing th...
-
4
Precision Medicine Commercialization: Strategic Pathways to Global Market Access
Lakshmi
Precision medicines now dominate US oncology approvals, yet a large share of eligible patients never reach the therapy matched to their biology. For American pharmaceutical leadership, commercializati...
-
5
Next-Generation RNA Therapeutics: Expanding the R&D Landscape Beyond Vaccines
Lakshmi
mRNA vaccines proved the chemistry; they did not define the category. Silencing, splicing, editing and in-vivo cell engineering have turned RNA into a mainstream pharmaceutical modality, with roughly...
press releasesRead more...
Immunome Announces EMA Validation of Marketing Authorization Application for Varegacestat for the Treatment of Adults with Desmoid Tumors
Immunome Inc a clinicalstage targeted oncology company committed to developing firstinclass and bestinclass targeted cancer therapies today announced that the European Medicines Agency EMA has validated the Marketing Authorization Application MAA for varegacestat an investigational oral oncedaily ga...
ILUMYA® (tildrakizumab-asmn) approved in the U.S. for the Treatment of Adults with Active Psoriatic Arthritis
Sun Pharmaceutical Industries Limited Reuters SUNBO Bloomberg SUNP IN NSE SUNPHARMA BSE Sun Pharma and includes its subsidiaries andor associated companies announced today that the US Food and Drug Administration FDA has approved the supplemental Biologics License Application
Eloxx Pharmaceuticals Announces FDA Clearance of Investigational New Drug Application for Exaluren in Nonsense-Mutation ADPKD
Eloxx Pharmaceuticals Inc a clinicalstage biopharmaceutical company developing exaluren for the treatment of rare kidney diseases today announced that the US Food and Drug Administration FDA has cleared the Companys Investigational New Drug IND application for exaluren for the treatment of nonsensem...
BioTalent Canada Launches BioReady Ontario to Connect AI Skills With Biomanufacturing Careers
BioTalent Canada is launching a new program BioReady Ontario to address two interconnected challenges affecting Ontarios bioeconomy building a skilled workforce and the adoption of emerging technologies like AI BioTalent Canadas labour market study projected that Canadas bioeconomy would require a...
Events Read more...
02 - 04
Nov 2026Pharma Forum EMEA 2026
Dom Pedro Lisboa Hotel, Lisbon...
02 - 04
Nov 2026Cancer R&D 2026
Houston, TX, USA
03 - 05
Nov 202610th Dermatology Drug Development
Boston, Massachusetts at The C...
03 - 04
Nov 2026PDA Aseptic Processing of Biopharma Conference
Sheraton Grand Incheon Hotel,...
04 - 05
Nov 2026Advanced Therapies USA
Hynes Convention Center, Bosto...
05 - 05
Nov 2026PDA Contamination Control Strategy Workshop
Sheraton Grand Incheon Hotel,...
09 - 11
Nov 202611th Microbiome Movement USA Summit
The Colonnade Hotel, Boston, M...
10 - 11
Nov 2026Extractables & Leachables Europe
Parkhotel Schӧnbrunn, Vienna,...
LATEST NEWSRead more...
Denali Therapeutics Receives 2026 Prix Galien USA Award for AVLAYAH® (tividenofusp alfa-eknm) as Best Biotechnology Product
Denali Therapeutics Inc announced that AVLAYAH tividenofusp alfaeknm has been recognized as the Best Biotechnology Product of by The Galien Foundation AVLAYAH is the first biologic approved by the US Food and Drug Administration FDA that is specifically designed to cross the bloodbrain barrier and...
Doximity Launches DoseCheck to Catch Dangerous AI Drug Dosing Errors Before They Reach Doctors
Doximity Inc the leading digital platform for US medical professionals has launched DoseCheck a free additional safety layer in Doximity Ask that instantly checks every AIgenerated medication dosing claim against a structured drug database to reduce treatment
Celularity and Vesalius Longevity Labs Sign Exclusive Collaboration for Peptual® Peptide APIs Manufactured in the United States
Celularity Inc a longevityfocused regenerative and cellular medicine company and Vesalius Longevity Labs Inc Vesalius a leading global peptide and longevity brand today announced that they have entered into an exclusive manufacturing agreement to establish a dedicated firstofitskind US final stage
Rakovina Therapeutics and Celvion Therapeutics Complete AI Analysis Identifying Priority Cancer Indications for Brain-Penetrant ATR Inhibitor Program
Rakovina Therapeutics Inc a biopharmaceutical company advancing innovative cancer therapies through AIpowered drug discovery and Bostonbased Celvion Therapeutics Celvion today announced the completion of the first analysis in their collaboration using Celvions EMphora
Manta Cares and Cancer Support Community SF Bay Area Partner to Bring AI-Powered Cancer Support to Northern California Patients and Families
Manta Cares a San Francisco company that builds AI for people with cancer and their families and Cancer Support Community San Francisco Bay Area CSC SFBA which has offered free support to people affected by cancer since today announced a partnership to offer a new level of support for people
Onco360® Has Been Selected as a National Pharmacy Partner for ZEGFROVY® (sunvozertinib)
Onco the nations leading independent Specialty Pharmacy has been selected as a national pharmacy partner by AstraZeneca Pharmaceuticals for Zegfrovy sunvozertinib which is indicated for the treatment of adult patients with locally advanced or metastatic nonsmall cell lung cancer NSCLC with epidermal...
